CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1) is a type I transmembrane glycoprotein expressed in epithelial cells with three or four extracellular domains (ECDs) and either long or short cytoplasmic domain isoforms. We have previously shown that the four extracellular domains, short cytoplasmic domain isoform, CEACAM1-4S, plays an essential role in lumen formation in an in vitro model of mammary morphogenesis. In this study, we transfected MCF-7 cells with either the long or short cytoplasmic domain isoforms of CEACAM1, and grew the cells in humanized mammary mouse fat pads in NOD/SCID mice. In this in vivo model, only the long cytoplasmic domain isoform, CEACAM1-4L, formed glands with lumen. On the basis of other studies that revealed phosphorylation of key Thr and Ser residues in the short cytoplasmic domain, we introduced phosphorylation mimic (for example, Thr or Ser to Asp) or null (Thr or Ser to Ala) mutations into the cytoplasmic domain of CEACAM1-4S and tested them in the in vivo model. Mutation of either Thr or Ser to Asp or the double mutant Thr þ Ser to Asp, but not the null mutants, induced gland formation with a central lumen-containing apoptotic cells. Moreover, the phosphorylation mimic mutants of CEACAM1-4S induced downregulation of b1-integrin, overexpression of b2-integrin, inhibited phosphorylation of focal adhesion kinase (pTyr-397) and resulted in myofibroblast differentiation as characterized by expression of vimentin, a-smooth muscle actin and b2-integrin, as well as the production of abundant extracellular matrix.
Introduction
CEACAM1 (carcinoembryonic antigen (CEA)-related cell adhesion molecule 1) is a CEA cross-reactive antigen (Svenberg et al., 1979) expressed on epithelial cells, activated endothelial cells and leukocytes (Obrink, 1997) . CEACAM1 is a type I transmembrane glycoprotein with either three or four Ig-like ectodomains and either a long (72-74 amino acids) or short (12-14 amino acids) cytoplasmic tail (Barnett et al., 1993) . CEACAM1 is downregulated in liver (Tanaka et al., 1997) , prostate (Busch et al., 2002) , colon (Neumaier et al., 1993) , lung (Ohwada et al., 1994) and breast cancers (Huang et al., 1998) . Transfection of the CEACAM1 gene into prostate (Luo et al., 1999) , bladder (Kleinerman et al., 1996a, b) , breast (Luo et al., 1997) , colon (Kunath et al., 1995) or liver (Laurie et al., 2005) cancer cell lines reduces the tumorigenic phenotype. While its downregulation in colon cancer occurs at the early adenoma stage (Nollau et al., 1997) , and in >90% of colon cancers (Neumaier et al., 1993) , only 30% of breast cancers have downregulation of CEACAM1 (Huang et al., 1998) .
We have shown that CEACAM1 plays an essential role in lumen formation in a three-dimensional model of mammary morphogenesis. MCF10F cells that expresses CEACAM1 form glands with a single layer of epithelium surrounding a central lumen when grown in Matrigel, and in the presence of anti-CEACAM1 antibody, lumen formation is inhibited (Huang et al., 1999) . MCF7 mammary carcinoma cells that do not express CEACAM1 or form lumen when grown in Matrigel are reverted to normal, when transfected with the CEACAM1-4S isoform (Kirshner et al., 2003a, b) . Since the in vitro studies lack several cell types present in the normal mammary gland, we have now evaluated the role of CEACAM1 isoforms in an in vivo model in which both the stromal and epithelial cells of the reconstructed mammary gland are of human origin (Kuperwasser et al., 2004) . The long cytoplasmic domain isoform, CEACAM1-4L, but not CEACAM1-4S-transfected MCF7 cells, are sufficient to form glands with lumen in the in vivo model. When residues Thr457 and Ser459 are mutated to the phosphorylation mimic Asp, but not Ala, they induce glandular lumen formation identical to the long cytoplasmic domain isoform. MCF7 cells expressing the phosphorylation mimic mutants of CEACAM1-4S or wild-type CEACAM1-4L modulated their expression of b-integrins, as well as phosphorylation of focal adhesion kinase, and promoted differentiation of fibroblasts into myofibroblasts that secrete abundant extracellular matrix (ECM).
Results
Comparison of CEACAM1-4S and -4L-transfected MCF7 cells in the humanized mammary fat pad model Although our previous studies demonstrated an essential role for CEACAM1-4S in an in vitro model of mammary morphogenesis (Huang et al., 1999; Kirshner et al., 2003a, b) , these studies did not include stromal cells or account for the potential role of the long cytoplasmic domain isoform, CEACAM1-4L, that is coexpressed in the epithelium of the mammary gland (Huang et al., 1998) . To evaluate CEACAM1-4S and -4L function in vivo, we adopted the humanized chimeric mouse mammary fat pad model (Kuperwasser et al., 2004) . Cleared mammary fat pads of NOD/SCID mice inoculated with immortalized human mammary fibroblasts are injected with MCF7 cells transfected with vector, CEACAM1-4S or -4L. The humanized fat pads were injected with cell suspensions rather than mammospheres as described in the original work. This change was important because we wanted to determine if the cell suspension could reorganize into glands without a prior environmental stimulus (for example, growth in Matrigel). After 8 weeks of growth, nodules 5-10 mm in diameter were harvested from the humanized fat pads and subjected to analysis by immunohistochemistry. Hematoxylin and eosin staining of the three types of samples (vector control, show that only the CEACAM1-4L-transfected MCF7 cells are capable of forming glandular structures with a single layer of epithelium surrounding a central lumen populated with apoptotic cells (characterized by condensed nuclei). In particular, the vector control cells form solid tumors (Figure 1a ), while the CEACAM1-4S-transfected cells form multilayered epithelium surrounding disorganized lumen ( Figure 1b) and 
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S Yokoyama et al CEACAM1-4L-transfected cells form complete glands with a central lumen (Figure 1c ). Immunostaining of serial sections with an anti-CEACAM1 antibody reveals no staining for the vector controls (Figure 1d ), diffuse staining for CEACAM1-4S-transfected cells ( Figure 1e ) and intense lumenal staining for the CEACAM1-4L-transfected cells (Figure 1f ). In addition, we have stained the cells with antibody M30 that only recognizes cleaved cytokeratin 18, which is specific for apoptotic cells (Leers et al., 1999) . This analysis reveals intense staining in the lumen of CEACAM1-4L-transfected cells (Figures 1g-i) , consistent with our previous data that demonstrated lumen formation occurs by apoptosis of the central luminal cells (Kirshner et al., 2003a, b) . , we conclude that CEACAM1-4S expression weakly induced vimentin expression in fibroblasts, whereas CEACAM1-4L strongly induced vimentin expression in fibroblasts. These results suggest that the interaction of MCF7 cells with surrounding fibroblasts is influenced by the expression of CEACAM1 and may induce differentiation of fibroblasts into myofibroblasts. The designation of these cells as myofibroblasts is partly based on their spindle shape morphology and their evident lining around the glandular epithelium (see Figure 2i ). Although the usual situation in the mammary gland is a glandular lining of myoepithelial cells, we have designated these vimentin þ smooth muscle actin-positive cells as myofibroblasts based on their origin from fibroblasts. Notably, myofibroblasts generate ECM and surround epithelial cells in many organs, including the colon (Powell et al., 2005) . In this in vivo model, we observe glandular epithelium surrounded by myofibroblasts and abundant ECM in CEACAM1-4L, but not in vector control or CEACAM1-4S-transfected MCF7 cells, grown in humanized mammary fat pads ( Figure 1 ). 
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We also performed immunostaining with b1-and b2-integrins, as well as phospho-FAK(Tyr-397), a marker for integrin activation. Staining for b1-integrin was focally positive for vector control cells and virtually absent for CEACAM1-transfected cells grown in humanized mammary fat pads (Figures 3a-c) . The lowered expression of b1-integrin in CEACAM1-transfected cells agrees with work by Bissell and co-workers, who showed that this integrin has lower expression in more differentiated mammary epithelium (Park et al., 2006) . On the other hand, b2-integrin expression is upregulated in the CEACAM1-transfected cells and in the surrounding myofibroblasts (Figures 3d-f) . Staining for phospho-FAK (Figures 3g-i ) was most intense for vector control cells (Figure 3i ), in agreement with other reports finding that phospho-FAK remains elevated in poorly differentiated epithelial cells (Mitra and Schlaepfer, 2006) .
Generation of CEACAM1-4S phosphorylation mimic mutants in transfected MCF7 cell lines
Since the above studies showed that CEACAM1-4S-transfected MCF7 cells failed to form glandular lumen 
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S Yokoyama et al in vivo, but were fully capable to form glandular lumen in vitro (Kirshner et al., 2003a, b) , it was important to determine whether this difference was due to posttranslational changes in the CEACAM1-4S protein or in the in vivo environment. We first considered posttranslational changes such as phosphorylation of Thr and Ser residues. Previous work by Obrink and co-workers have shown that Thr and Ser residues in rat CEACAM1-4S can be phosphorylated by protein kinase C isozymes (Edlund et al., 1998) , and recent work in our lab have shown residues Thr457 and Ser459 in human CEACAM1-4S were transiently phosphorylated during glandular lumen formation in vitro (Chen et al., 2007) . To test the hypothesis that phosphorylation of these residues was responsible for the differences seen between the two model systems, we generated mutants T457D, T457A, S459D, S459A, T457D þ S459D and T457A þ S459A. The D (Asp) mutants were made to mimic phosphorylated forms of T457 and S459, whereas the A (Ala) mutants were null. CEACAM1-4S-transfected MCF7 cells lines were established for each mutant, as well as for wild-type CEACAM1-4S and -4L. Each cell line (but to a lesser extent in the double D mutant) had high expression of CEACAM1 as shown by western blot analysis (Figure 4 ).
CEACAM1-4S phosphorylation mimic mutants form acini in mammary humanized fat pads
We used wild-type CEACAM1-4S-transfected MCF7 cells as the control for the CEACAM1-4S mutants (see Figure 1 ). Single mutants T457D and S459D, and double mutant T457D þ S459D in transfected MCF7 cells formed simple epithelium (Figures 5a-c) , with a single layer of epithelial cells surrounding a central lumen that was moderately positive for CEACAM1 (Figures 5d-f ) in the central apoptotic cells and strongly positive for cleaved CK18 (Figures 5g-i) . On the other hand, the null mutants T457A, S459A and T457A þ S459A in transfected MCF7 cells formed multilayered, stratified epithelium with formation of pseudolumen ( Figure 6 ). These results demonstrate that phosphorylation mimic CEACAM1 isoforms in lumen formation S Yokoyama et al mutations at either Thr457 or Ser459 (or both) of CEACAM1-4S can induce glandular formation with simple glandular epithelium in the in vivo model. In contrast to the wild-type CEACAM1-4S-transfected MCF7 cells grown in humanized mammary fat pads, the phosphorylation mimic mutants have reduced b1-integrin (Figures 7a-c) and phospho-FAK (Figures 7d-f ) expression, indicating a more differentiated phenotype. Importantly, the staining pattern for b2-integrin is dramatically altered in the phosphorylation mimic mutants compared to wild-type CEACAM1-4S. Staining for b2-integrin is intense in spindle-shaped cells surrounding the acinar glands and is found within the central lumen-containing apoptotic cells (Figures 7g-i) . As mentioned above, we have assigned the b2-integrinpositive spindle cells surrounding these glands as myofibroblasts, based on their morphology and expression of smooth muscle actin and vimentin. Samples stained for cytokeratin 8/18 show intense staining for glandular epithelial cells but not surrounding (myo) fibroblasts (Figures 8a-c) . Samples stained for vimentin or smooth muscle actin show intense staining for spindle-shaped cells surrounding the acinar glands but not the glandular epithelium (Figures 8d-i) . In contrast to wild-type CEACAM1-4S-transfected MCF7 cells grown in humanized mammary fat pads, the phosphorylation mimic mutants have higher intensity and more widespread staining for both vimentin and b2-integrin, thus indicating an effect of phosphorylation on CEA-CAM1-4S that affects not only glandular epithelium development but also myofibroblast differentiation, and this correlates with vimentin and b2-integrin expression in the surrounding stromal cells.
Discussion
The downregulation of CEACAM1 in colon epithelial cells occurs in hyperplastic polyps (Nittka et al., 2004) , early adenomas (Nollau et al., 1997) and in colon cancers (Neumaier et al., 1993) to the same extent 
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S Yokoyama et al (ca 90%). In contrast, only 30% of breast cancer exhibit downregulation of CEACAM1 (Huang et al., 1998) . However, similar to colon carcinoma, breast carcinomas lose their normal histological morphology, including formation of stratified epithelium. As shown here, stratified epithelium may also result from less short cytoplasmic domain isoform phosphorylation, but normal morphology is restored by expression of the long cytoplasmic domain isoform. While CEACAM1-4S functions normally in the in vitro model where the system is optimized for morphogenesis (that is, presence of abundant ECM), it functions suboptimally in the in vivo model, as if it is missing a critical factor. We hypothesize that the function of CEACAM1-4S is impaired in breast cancer compared to normal breast, thus accounting for the observation that it is downregulated in only 30% of breast cancers. The loss of function of CEACAM1-4S is likely due to decreased phosphorylation of Thr and Ser residues in the short cytoplasmic domain. Evidence for phosphorylation of these residues is provided by the studies on rat CEACAM1-4S (Edlund et al., 1998) and more recent studies on human CEACAM1-4S (Chen et al., 2007) . We demonstrate here that phosphorylation mimic, but not null mutations, can restore the function of CEACAM1-4S-transfected MCF7 cells in the in vivo model. Since enforced phosphorylation (in the phosphorylation mimic mutants) leads to glandular lumen formation surrounded by abundant ECM, it appears that phosphorylation of CEACAM1-4S in epithelial cells is responsible for production of abundant ECM. The stromal cells appear to make little vimentin and b2-integrin in the case of wildtype CEACAM1-4S, but differentiate into vimentinpositive and b2-integrin-positive myofibroblasts in the case of the phosphorylation mimic mutants of CEA-CAM1-4S. Since myofibroblasts are known to make abundant ECM in areas of wound healing (Powell et al., 1999) , the differentiation of fibroblasts into myofibroblasts must be an essential step in the de novo formation of acini with lumen in this model system.
The myofibroblast has smooth muscle cell characteristics (Tomasek et al., 2002) and expresses cytokines and adhesion proteins (Powell et al., 1999) . Importantly, b2-integrin expression is observed during myofibroblast CEACAM1 isoforms in lumen formation S Yokoyama et al differentiation (Peters et al., 2005) , agreeing with our data in which either CEACAM1-4L or phosphorylation mimic mutants of CEACAM1-4S-transfected MCF7 cells promoted increased b2-integrin expression on nascent myofibroblasts. Others have shown that b2-integrin is important for myofibroblast differentiation and that b2-integrin knockout mice have impaired myofibroblast differentiation (Peters et al., 2005) . Furthermore, activation of FAK is thought to reverse myofibroblast differentiation (Greenberg et al., 2006) . Thus, phosphorylation of CEACAM1-4S in epithelial cells, inhibition of FAK activation in the same epithelial cells and surrounding myofibroblast differentiation, ultimately result in the production of abundant ECM and glandular lumen formation.
Although the cytoplasmic domain of CEACAM1-4S contains only 12-14 amino acids, this domain can bind actin, tropomyosin, annexin II and calmodulin (Schumann et al., 2001) . The long cytoplasmic domain isoform of CEACAM1 can also induce acinar lumen formation without the need for phosphorylation mimic mutations. Since the cytoplasmic domains of the two isoforms are identical for the first six amino acids, including Thr457, then differ, we predict that Thr457 is the key residue for phosphorylation. In addition, the long cytoplasmic domain has two tyrosines in an immunoreceptor tyrosine-based inhibitory motif (ITIM) that can be phosphorylated by Src kinases (Brummer et al., 1995) , and once phosphorylated can bind SHP-1 and -2 phosphatases (Huber et al., 1999) . This domain has also been shown to bind actin and tropomyosin (Schumann et al., 2001) .
In conclusion, wild-type CEACAM1-4L formed glandular epithelium with a central lumen, whereas wild-type CEACAM1-4S formed stratified epithelium in humanized mammary fat pads. However, phosphorylation mimic mutants at either Thr457 or Ser459 (or both), but not null mutants in CEACAM1-4S were able to restore glandular lumen formation. Thus, phosphorylation of these residues plays a key role in the function of CEACAM1-4S. Furthermore, phosphorylation mimic mutants of CEACAM1-4S, as well as wild-type CEA-CAM1-4L, induced myofibroblast differentiation in the surrounding stroma. These findings suggest that loss of 
S Yokoyama et al CEACAM1-4S function in breast carcinoma tissues may be responsible for loss of normal tissue architecture.
Materials and methods
Cell lines and selection of stable cell lines MCF7 cells were from ATCC (Manassas, VA, USA) and immortalized human fibroblasts from Dr C Kuperwasser. CEACAM1-4L-transfected MCF7 cells (Kirshner et al., 2003a, b) and phosphorylation mimic and null mutants of CEACAM1-4S derived by site-directed mutagenesis (Chen et al., 2007) were described previously. CEACAM1-4S mutants were cloned into the pHb-actin vector, electroplated into MCF7 cells and selected in medium containing 1.0 mg/ml neomycin.
Western blotting
Proteins (30-50 mg) from 1% NP40 cell lysates were separated by sodium dodecyl sulfate-gel electrophoresis, transferred to nitrocellulose membranes and probed with anti-CEACAM1 T84.1 (1 mg/ml) (Wagener et al., 1983) and b-actin (Abcam, Cambridge, UK) antibodies. Signals were detected on the Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, NE, USA).
Animals and surgery
The humanized mammary chimeric fat pad mouse model (Kuperwasser et al., 2004) was followed except single cells (2.0 Â 10 5 ) rather than mammospheres were injected into the humanized site. Briefly, 2 Â 10 5 unirradiated RMF/EG fibroblasts and 2 Â 10 5 irradiated (4 Gy) fibroblasts were injected into cleared mammary fat pads of NOD/SCID mice, and 2 weeks later, CEACAM1-transfected MCF7 cells (2 Â 10 5 ) plus 2 Â 10 5 fibroblasts in 35 ml of collagen I/Matrigel (3:1) were injected into the humanized fat pads. Eight weeks later the xenografts were removed for analysis.
Histology and immunohistochemistry
Xenografts were fixed in 10% neutral-buffered formalin, subjected to antigen retrieval (Shi et al., 2001 ) and stained with anti-CEACAM1 26H7 (Dr RS Blumberg), anti-CK8 þ 18 (Invitrogen, Carlsbad, CA, USA), anti-M30 (Roche, Indianapolis, IN, USA), anti-SMA (Dako, Carpenteria, CA, USA), anti-vimentin (Dako), anti-b1 or b2-integrin (Chemicon, Temecula, CA, USA), or anti-phosphoFAK (BD Transduction Laboratories, San Jose, CA, USA) antibodies. Immunocomplexes were visualized by the ABC peroxidase method, and sections were counterstained with hematoxylin.
